RxDoctor Payments Data

David Kovacevic, MD

Sports Medicine · New York, NYNPI 1841463122

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Linvatec Corporation accounts for 62.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $16,595 and has fallen 97.0% since, to $490 in 2025.

$35,144in general payments, 2019–2025

Across 102 payments — averaging $344.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$22K
  • Seapearl East, Inc$3K
  • Johnson & Johnson$2K
  • Ossio Inc$2K
  • Gotham Surgical Solutions & Devices, Inc.$2K
  • Geistlich Pharma, North America, Inc.$1K
  • plus $3K from 20 others

What the payments were for

  • Consulting fees$17,00048%
  • Travel & lodging$5,92817%
  • Food & beverage$7,94323%
  • Education$4,22612%
  • Entertainment$480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,144 in reported general payments places this provider in the 85th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York

Medicare billing

Part B allowed, 2024
$38,608
Medicare patients
73
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam15$71
Oxycodone Hcl14$46

Paid to pharmacies, not to this prescriber.

Other sports medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →